INOVIO PHARMACEUTICALS, INC. Lessee, Operating Lease, Liability, to be Paid, Year One
INOVIO PHARMACEUTICALS, INC. (INO) had Lessee, Operating Lease, Liability, to be Paid, Year One of $2.99 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Notes › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths · last filed 2026-08-12
- 2026-06-30: Lessee, Operating Lease, Liability, to be Paid, Year One $2.99M.
- 2026-03-31: Lessee, Operating Lease, Liability, to be Paid, Year One $2.99M.
- 2025-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $3.59M.
- 2025-09-30: Lessee, Operating Lease, Liability, to be Paid, Year One $3.59M.
| Period end | Lessee, Operating Lease, Liability, to be Paid, Year One |
|---|---|
| 2026-06-30 | $2.99M 10-Q · filed 2026-08-12 |
| 2026-03-31 | $2.99M 10-Q · filed 2026-05-13 |
| 2025-12-31 | $3.59M 10-K · filed 2026-03-12 |
| 2025-09-30 | $3.59M 10-Q · filed 2025-11-10 |
| 2025-06-30 | $3.59M 10-Q · filed 2025-08-12 |
| 2025-03-31 | $3.59M 10-Q · filed 2025-05-13 |
| 2024-12-31 | $3.48M 10-K · filed 2025-03-18 |
| 2024-09-30 | $3.48M 10-Q · filed 2024-11-14 |
| 2024-06-30 | $3.47M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $3.47M 10-Q · filed 2024-05-13 |
| 2023-09-30 | $3.05M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $3.05M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $3.05M 10-Q · filed 2023-05-10 |
| 2022-09-30 | $4.09M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $4.09M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $4.09M 10-Q · filed 2022-05-10 |
| 2021-09-30 | $4.08M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $4.04M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $4.04M 10-Q · filed 2021-05-10 |
| 2020-09-30 | $3.97M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $3.97M 10-Q · filed 2020-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |